Sort
64,565 grants matching “drug discovery”
Synergistic patterned neurodegeneration by APP and APOE4
$1,924,895Jonathan T Pierce-Shimomura · University Of Texas At Austin · RF1 · FY2017 · AG
COBRE Center for Antimicrobial Resistance and Therapeutic Discovery
$1,923,357Eleftherios Mylonakis · Miriam Hospital · P20 · FY2018 · GM
The role of TREM2 in human microglial function and Alzheimer disease pathogenesis
$1,921,750Mathew Mark Blurton-Jones · University Of California-Irvine · RF1 · FY2014 · AG
Autophagy-Inducting Peptides and Target Identification for Treatment of Viruses
$1,921,640Beth C Levine · Washington University · U19 · FY2016 · AI
Rat Genome Database
$1,920,225Mary E Shimoyama · Medical College Of Wisconsin · R01 · FY2016 · HL
Biorepository and Coordinating Center for Studies on Cardiovascular Complications of Human Type 1 Diabetes
$1,919,864Mark A Atkinson · University Of Florida · U24 · FY2025 · DK
Biorepository and Coordinating Center for Studies on Cardiovascular Complications of Human Type 1 Diabetes
$1,918,039Mark A Atkinson · University Of Florida · U24 · FY2024 · DK
Interdisciplinary Approach to Alzheimer Drug Discovery
$1,917,793Samuel E Gandy · Thomas Jefferson University · P01 · FY2006 · AG
Non-invasive Neuromodulation Unit (NNU)
$1,917,770Sarah Lisanby · National Institute Of Mental Health · ZIA · FY2017 · MH
Emory/Atlanta Center for AIDS Research
$1,917,457James W. Curran · Emory University · P30 · FY2009 · AI
Biology and Novel Therapeutics of Cardiovascular Peptides
$1,916,871John C Burnett · Mayo Clinic Rochester · P01 · FY2012 · HL
Structure-based Discovery of Critical Vulnerabilities of Micobacteria
$1,915,116James C Sacchettini · Texas A&M University · P01 · FY2015 · AI
Structure-based Discovery of Critical Vulnerabilities of Micobacteria
$1,915,116James C Sacchettini · Texas A&M University · P01 · FY2014 · AI
University of Hawaii Cancer Center CCSG
$1,913,800Randall F Holcombe · University Of Hawaii At Manoa · P30 · FY2018 · CA
DEVELOPMENTAL BIOLOGY OF HUMAN ERYTHROPOIESIS
$1,913,102Stuart H Orkin · Boston Children'S Hospital · P01 · FY2013 · HL
Establishment of Laboratory of Molecular Imaging and Nanomedicine
$1,912,399Xiaoyuan Chen · National Institute Of Biomedical Imaging And Bioengineering · ZII · FY2009 · EB
COVID-19: Assay Development, HTS and Drug Repurposing to identify potential therapeutics against SARS-CoV-2
$1,912,140Matthew Hall · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
Endocannabinoids And Energy Homeostasis
$1,910,818George Kunos · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2012 · AA
Genetic variant-based drug discovery targeting conserved pathways of aging
$1,910,686Jan No Middle Name Vijg · Albert Einstein College Of Medicine, Inc · U19 · FY2017 · AG
ADULT AIDS CLINICAL TRIALS UNIT
$1,910,152Ohio State University · U01 · FY2001 · AI
Cellular and Molecular Mechanisms of Acute Lung Injury in Sickle Cell Disease
$1,909,806Clinton H. Joiner · Emory University · U01 · FY2016 · HL
Cellular and Molecular Mechanisms of Acute Lung Injury in Sickle Cell Disease
$1,909,806Clinton H. Joiner · Emory University · U01 · FY2017 · HL
Enhancing ATG-dependent Defense Against Pathogens w/Therapeutics Lead CP
$1,909,477Stuart L Schreiber · Washington University · U19 · FY2016 · AI
ADULT AIDS CLINICAL TRIALS UNIT
$1,909,378Ohio State University · U01 · FY2000 · AI
Interdisciplinary center of excellence for the study of pain and sensory function
$1,909,244Ian D Meng · University Of New England · P20 · FY2014 · GM